Cassava Sciences, Inc.
SAVA
$3.10
$0.217.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -22.69% | -62.56% | |||
| Gross Profit | 22.69% | 62.56% | |||
| SG&A Expenses | -11.93% | 13.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.84% | -34.72% | |||
| Operating Income | 15.84% | 34.72% | |||
| Income Before Tax | 75.56% | -88.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 75.56% | -88.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 75.56% | -88.97% | |||
| EBIT | 15.84% | 34.72% | |||
| EBITDA | 15.46% | 35.07% | |||
| EPS Basic | 75.57% | -88.80% | |||
| Normalized Basic EPS | 16.39% | 36.71% | |||
| EPS Diluted | 75.68% | -89.73% | |||
| Normalized Diluted EPS | 16.39% | 36.71% | |||
| Average Basic Shares Outstanding | 0.00% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||